News

warning safety alert recall healthcare issue

AstraZeneca has stopped selling Andexxa, a factor Xa inhibitor anticoagulant reversal agent the FDA first approved in 2018, because patients may face an increased risk of experiencing a blood clot or stroke. The company emphasized that it remains confident in the agent's abilities.

Abbott Volt Pulsed Field Ablation

The Volt Pulsed Field Ablation System from Abbott has been approved by the FDA. The technology, which gained CE mark approval in March, features a one-of-a-kind catheter design and allows patients to be treated under conscious sedation.

artificial intelligence money finance acquisition

The key agency released a request for information on Dec. 19, asking for broad input on how it can accelerate the adoption of AI in clinical care. 

money court scale of justice ruling legal settlement

Patients first sued the St. Louis Park, Minnesota-based imaging group in two separate lawsuits, both filed in 2023, over its use of tracking pixels to allegedly filter info to Facebook and other third parties. 

Thumbnail

Founded in 2023, Hunterbrook is an investigative news and investment outlet, which creates reports criticizing publicly traded companies and then benefits from the corresponding drop in share prices

Thumbnail

Ferumoxytol is used primarily in medications that treat anemia, but the FDA recently cleared it for deployment in brain imaging as well.

Thumbnail

The tool also can be used on contrasted abdominal scans completed for other clinical indications, addressing suspicious lesions before they worsen.  

Department of Justice DOJ

The U.S. Department of Justice has formally accused Done Global of unlawfully distributing ADHD medications without medical need, using a subscription program and targeted advertising to find patients searching for drugs. The company is also accused of filing false medical claims to Medicare, Medicaid and commercial insurance. Done's founder and CEO was convicted last month on related charges and awaits sentencing. 

pediatric pacemaker

A team of pediatric specialists worked closely with representative from Medtronic to develop the new pacemakers. Overall, the tiny devices—approximately one-quarter the size of a traditional pacemaker—were found to be both safe and effective. They are still under development.

These findings may lead to new screening guidelines that could change how imaging is utilized in the aging population.

primary care provider clinician physician doctor

Nominees for the Cardiovascular Business Forty Under 40 Awards can now be submitted through Sunday, March 9.

Capstan Medical robotic transcatheter mitral valve replacement

One of the cardiologists involved in the procedures said they represent "a significant leap forward in structural heart intervention."

Around the web

AstraZeneca has stopped selling Andexxa, a factor Xa inhibitor anticoagulant reversal agent the FDA first approved in 2018, because patients may face an increased risk of experiencing a blood clot or stroke. The company emphasized that it remains confident in the agent's abilities.

The Volt Pulsed Field Ablation System from Abbott has been approved by the FDA. The technology, which gained CE mark approval in March, features a one-of-a-kind catheter design and allows patients to be treated under conscious sedation.

The key agency released a request for information on Dec. 19, asking for broad input on how it can accelerate the adoption of AI in clinical care.